Given the success of approved CAR-T cell therapies, such as KYMRIAH®, YESCARTA®, TECARTUS® and BREYANZI®, this upcoming class of biologics are anticipated to carve out a significant share of the multi-billion dollar cancer immunotherapy market
Roots Analysis has announced the addition of “CAR-T Cell Therapies Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Hepatocellular Carcinoma and Others), Target Antigens (CD19, BCMA, CD19 / CD22, GPC3 and EGFR), Key Players and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World) – Industry Trends and Global Forecasts, 2021-2030” report to its list of offerings.
Given their ability to selectively direct a cell mediated immune response against cancer cells and, thereby, offer prolonged periods of disease remission, several CAR-T cell therapies provide a promising therapeutic strategy for advanced stage cancers and are expected to achieve blockbuster status. With four approved products and many candidate therapies under evaluation for the treatment of multiple disease indications, the CAR-T cell therapy market is characterized by a healthy and growing pipeline. Further, with lucrative financial support and notable increase in partnerships, the CAR-T-cell therapies market is abuzz with activity.
To order this 795+ page report, which features 165+ figures and 270+ tables, please visit https://www.rootsanalysis.com/reports/view_document/car-t-therapies-market/269.html
Key Market Insights
Over 755 CAR-T cell therapies are currently approved / under development
Close to 40% of the aforementioned candidates are in preclinical and discovery stages, while more than 25% are being evaluated in clinical stages (phase I/II and above). Examples of late-stage clinical candidates include bb2121, CD123/CLL1 CAR-T CD19 CAR-T and LCAR-B38M CAR-T / JNJ-68284528.
Currently, the focus is on developing product candidates to treat various types of cancers
Over 95% of the products in the development pipeline are being evaluated for the treatment of hematological malignancies, including (in decreasing order of number of pipeline products) acute lymphoblastic leukemia, non-Hodgkin's lymphoma, multiple myeloma, and acute myeloid leukemia. Only 2% of current pipeline candidates are being developed for the treatment of non-oncological indications.
Extensive efforts are underway to improve CAR constructs
Majority of the product candidates in the clinical pipeline, including the four approved drug products, are based on second generation CARs. Further, a number of novel therapies armed with fourth generation CAR constructs, CAR-based products containing humanized scFv and bispecific CARs (CD19+CD20 or CD19+CD22 or CD19+CD30) are being evaluated worldwide.
To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/269/request-sample.html
The USD 14 billion (by 2030) financial opportunity within the CAR-T cell therapy market has been analyzed across the following segments:
§ Key Geographical Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and North Africa
- Rest of the World
For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/car-t-therapies-market/269.html or email [email protected]
You may also be interested in the following titles:
1. Global T-Cell Therapies Market (5th Edition), 2021 – 2030
2. mRNA Therapeutics and Vaccines Market, 2020-2030
3. Gene Therapies Market (4th Edition): Industry Trends and Global Forecasts, 2020-2030
4. Oncolytic Virus Therapy Market: Pipeline Review, Developer Landscape and Competitive Insights, 2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]
Contact Details
Ben Johnson
+1 (415) 800 3415
Roots Analysis
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis.com
Medium: https://medium.com/@RootsAnalysis
Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/
Quora: https://rootsanalysisinsights.quora.com/
Human factors engineering and usability testing have now become an essential part of product design across almost all industries, offering developers the chance to optimize proprietary products in alignment to the preferences of consumers London Roots Analysis has announced the addition of “Human Factors Engineering and Usability Testing Services Market for Medical Devices, 2020-2030” report to its list of offerings.
Moreover, as such solutions are gradually becoming increasingly complex, it is imperative to identify potential risks / hazards, in order to guarantee safety to end users post product launch.
However, the aforementioned processes require specialized resources and expertise.
Therefore, outsourcing this aspect of product design and development, has become common among industry stakeholders.
To order this 200+ page report, which features 120+ figures and 100+ tables, please visit this link Key Market Insights Around 105 companies / organizations claim to be engaged in offering human factors engineering and usability testing services for medical devicesIt is worth noting that this market is currently dominated by the presence of small players (2 to 50 employees), which represent more than 67% of the players.
Majority (57%) of the players engaged in this domain offer services for hospital / laboratory equipment and instruments Various companies (53%) engaged in this domain claim to offer human factors engineering and usability testing services for diagnostic devices, followed by those providing support for drug delivery devices (44%), home use medical devices (36%), clinical use devices (26%) and therapeutic devices (25%).
The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities to service providers serving this niche, but growing market segment London Roots Analysis has announced the addition of the “Microbial Contract Biomanufacturing Market, 2020-2030” report to its list of offerings.
Despite mammalian cell cultures being the preferred manufacturing approach for biologics, recent advances in microbial fermentation have enabled the development of versatile biomanufacturing systems, which are both robust and cost friendly.
Presently, a number of service provider companies claim to offer end-to-end solutions, ranging from product development to commercial production, for microbial biologics.
Europe is currently regarded as a key manufacturing hub for microbial biologicsThere are more than 150 manufacturing facilities, with microbial fermentation capabilities, worldwide; of these, 43% are in Europe, followed by North America (31%).
On the other hand, prominent regions in the Asia Pacific and Middle East, where microbial biologics are manufactured, include (in decreasing order of number of resident manufacturing facilities) China, India, Japan, Australia and Israel.
Further, a large number (~25%) of the partnerships were observed to be focused on the production of microbial biologics; this is followed by process development and manufacturing agreements (20%).
Research Report Insights (RRI) delivers key insights on the global hand tools market in its latest report titled ‘Hand Tools Market by 2027.’ The long-term outlook on the global hand tools market remains positive, with market value expected to increase at a CAGR of 3.9% by 2027. Among application, the household & DIY segment is expected to expand at a significant CAGR in terms of value over the forecast period. Among product type, the metal cutting tools segment is anticipated to witness higher CAGR in terms of value over the forecast period. Global sales offhand tools is estimated to be valued at US$ 15,642.8 Mn by the end of 2017, witnessing a Y-o-Y growth of 3.9% over the year 2016. North America is estimated to account for a value share of 33.3% in the global hand tools market by 2017 end and it is anticipated to retain its dominance throughout the forecast period.
Report For Report Sample with Table of Contents@https://www.researchreportinsights.com/report/sample/110114717/Cosmetic-Ingredients-Market
Hand Tools has been identified as one of the most profitable and consistently performing industry despite being low profile. Use of hand tools is largely affected by the demographic conditions with majority of consumer’s utilizing hand tools for several DIY (do it yourself) and remodeling activities. On the other hand, in industries use of hand tools has been largely characterized by companies looking for state of art technology to produce high quality products. To respond to the needs of industries, producers are aggressively focusing towards product innovation to satisfy the needs of different customers. One of the several areas of product innovation where companies are primarily focusing is ergonomic design of hand tools to make it more precise and comfortable to operate. Industrial expansion worldwide is primarily driving the demand for hand tools since adoption of hand tools for several maintenance purpose is continuously increasing. Further, emerging demand of hand tools from automotive repair and maintenance industry has also witnessed the growth of high precision hand tools.
However, the global hand tools market is expected to face certain challenges. Consumer shifting preference towards power tools mainly due to fast and easy operating feature is primarily restricting the growth of the market. Moreover, raw material price rise is also identified as the challenge for the companies to maintain price quality ratio of hand tools primarily during shifting trend toward adoption of power tools. The segment is anticipated to account for a market value of more than US$ 9,000 Mn in 2017 and is anticipated to be valued in excess of US$ 12 Bn by 2027 end, expanding at a CAGR of 3.9% during the projected period.
Request For Report Discount@https://www.researchreportinsights.com/report/discount/110114717/Cosmetic-Ingredients-Market
Segmentation analysis
- On the basis of product type, the general purpose tools segment is anticipated to continue to dominate the market in terms of value over the forecast period
- On the basis of application, the industrial segment is anticipated to dominate the market in terms of value. This segment accounted for 59.9% value share in 2015
- On the basis of sales channel, the online sales segment is expected to be the most attractive in terms of CAGR index. The growth of this segment is due to rising penetration of e-commerce and increasing demand for cross border products among consumers.
- In terms of sales channel, retail segment is expected to dominate the market throughout the forecast period. Mass merchant retailers selling product at price below industry average in order to drive their sales is primarily fuelling the growth of this segment.
Regional analysis
North America and Western Europe are estimated to collectively account for 63.8% value share in the global hand tools market by the end of 2017. The North America hand tools market is expected to remain dominant over the forecast period. Although power tools are continuously replacing hand tools in North America and Western Europe, increasing product innovations and companies aggressive expenditure in R & D is expected to propel the growth of the market. Mexico is expected to hold dominant revenue share in the Latin America hand tools market over the forecast period. This is primarily due to higher per capita consumption of hand tools. Sales of hand tools in APEJ is expected to increase to US$ 3,916.8 Mn by 2027 end from US$ 2,186.0 in 2017.
Report Analysis@https://www.researchreportinsights.com/report/rd/110114717/Cosmetic-Ingredients-Market
Vendor insights
The report highlights and presents the market value share of some of the top companies operating in the global hand tools market such as Stanley Black Decker, Apex Tools Group, Snap-On, Klein Tools, Akbar Tools Ltd., Wera Tools, Channellock, Inc., JK Files (India) Limited and Kennametal Inc.
The Biofertilizers Market Research Report 2019 gives an extensive evaluation of the industry to help the reader gain the upper hand in the competitive landscape by employing optimal tactics and understanding the essential market elements in the Biofertilizers sector.
Through the statistical analysis performed in the report, it is visible that the market will continue to grow at a steady pace in the coming years, alongside the changing market dynamics.This report covers the recent COVID-19 incidence and its impact on Biofertilizers.
To get a Free Sample PDF Brochure of the Biofertilizers Market Research Report, Visit @ https://www.reportsanddata.com/sample-enquiry-form/1774Firstly the report gives the Holistic view of the market evaluated in terms of size, share, market value, production, and regional analysis of the Biofertilizers sector.
Furthermore, the report provides a detailed examination of other aspects including the factors boosting the growth of the market, regulatory policies, technological innovations, good prospects, impact analysis of drivers and restraints, and other factors affecting the demand and supply dynamics of the Biofertilizers market.
These market aspects collectively form part of the overall market analysis performed in the report to forecast estimated values for the same for the forecast period from 2019 to 2026.Leading Players included in the Biofertilizers report are:Biomax, Bodisen Biotech, Inc., Camson Bio Technologies Limited, Italpollina SpA, Lallemand Inc., Novozymes A/S, PotashCorp Agri Life, Protan AG, Stanes & Company Limited, Rizobacters Argentina S.A Biofertilizers Market Basic Segmentation: Market has been divided by Product as:Nitrogen Fixing Bio-FertilizerPhosphate Mobilizing Bio-FertilizerPotassium Mobilizing Bio-FertilizerOthers Market has been divided by Technology Type as:Carrier Enriched BiofertilizersLiquid BiofertilizersOthers Market has been divided by Application as:Seed TreatmentSoil Treatment Get the Discount on the Biofertilizers Report @ https://www.reportsanddata.com/discount-enquiry-form/1774 Additionally, the report categorizes the market into different segments of the Biofertilizers market and breaks down the details into various segments and subsequent for or better understanding.
The detailed analysis included in the study gives a holistic overview of the different aspects affecting the development of the market, as observed in the historical and present market analysis and the projected future of the industry.
This report studies Wireless Gigabit Market with SWOT analysis, Market Share, Restraint analysis, Segmentation, Insights, Growth, Application, Trends, Market driver analysis, Revenue and Competitive analysis in these regions, forecast to 2025. This report focuses on top manufacturers in Global Market
Global Wireless Gigabit (WiGig) Market is anticipated to reach USD 7.42 billion by 2024. Wireless Gigabit (WiGig) is designed to render faster speed for wireless network connections.
The factors that propel the growth of the Wireless Gigabit Market include increase in the demand for bandwidth, saturation of smartphones and use of several devices that are eventually contributing to the overall industry development. On the other hand, there are factors that may hamper the growth of the market including rise in the cost of IPAM.
To begin understanding compliance, healthcare organizations would be wise to consider three key recommendations.
Analyze the past to avoid making the same mistake twice It is important for hospitals and healthcare facilities to look at some of the common mistakes that are repeatedly noted in HIPAA security reviews.
This includes impermissible uses and disclosures of protected health information, lack of safeguards to protect health information, lack of patient access to their personal health information, lack of administrative safeguards on electronic protected health information, and use or disclosure of more than the minimum protected health information.
Protecting valuable data by analyzing past mistakes is an important step in the compliance process.
The confusion and lack of understanding around the two examinations has been common among healthcare professionals in the marketplace for some time.
According to HHS and Office for Civil Rights (OCR) guidelines, all healthcare organizations must specifically conduct a risk analysis to be considered within HIPAA compliance.
